Diagnostics Receives an Updated Impact Factor of 3.8 and an Increased CiteScore of 6.9

We are pleased to share that Diagnostics (ISSN 2075-4418) has been awarded an increased Impact Factor of 3.8 in the 2025 Journal Citation Reports™ released by Clarivate™ in June 2026, ranking in Q1 in the "Medicine, General and Internal" category.

Additionally, the journal has received an increased CiteScore of 6.9 this month, ranking in Q1 (top 25%) in both “Clinical Biochemistry” and “Internal Medicine” categories.

To learn more, please visit our journal statistics website
(https://www.mdpi.com/journal/diagnostics/stats) for detailed metrics.

The support and dedication of all our editors, reviewers, authors, and readers are integral to the journal’s success. We would like to take this opportunity to thank everyone who has contributed to the journal.